Clinical Trials
67 trialsA Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
BIIRTH
Tuen Mun Hospital
TRIPLET
Federation Francophone de Cancerologie Digestive
A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma
Nanjing Sanhome Pharmaceutical, Co., Ltd.
ALICE
UNICANCER
Cocktail-001
Shanghai Zhongshan Hospital
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Peking University
ABATE-MASLD
Eastern Hepatobiliary Surgery Hospital
ALIVE
Mirror Biologics, Inc.
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
Zhujiang Hospital
LIVIGNO-2
AbbVie
HPB70+
Assistance Publique - Hôpitaux de Paris
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
SH-LPS System in Preoperative Planning for Liver Resection
Zhejiang Cancer Hospital
TACE-3
The Clatterbridge Cancer Centre NHS Foundation Trust
Camrelizumab Combined with Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) As Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)
Shanghai Zhongshan Hospital
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
HCC
Sinocelltech Ltd.
Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC
Guangxi Medical University
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
Third Affiliated Hospital, Sun Yat-Sen University
A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
Qilu Pharmaceutical Co., Ltd.
ARTEMIS
THERABIONIC INC.
JUPITER 04
Shanghai Junshi Bioscience Co., Ltd.
HCC
Shandong New Time Pharmaceutical Co., LTD
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
Zhongda Hospital
TACE Combined With Penpulimab and Anlotinib for Advanced HCC
Zhongda Hospital
Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC
West China Hospital
TACE-SBRT
Tata Memorial Hospital
SATURNE
Federation Francophone de Cancerologie Digestive
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ISBRT01
Sun Yat-sen University
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
Chinese PLA General Hospital
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
Innovent Biologics (Suzhou) Co. Ltd.
Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE
Fudan University
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Ivy Life Sciences, Co., Ltd
LLTHVV
RenJi Hospital
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Sun Yat-sen University
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
RenJi Hospital
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
Guangxi Medical University
LD-FOX4/HCC
Guangxi Medical University
Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
Guangxi Medical University
Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma
Guangxi Medical University
Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma
Guangxi Medical University
The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial
Sun Yat-sen University
Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
Qingdao Central Hospital
START
Asan Medical Center
HAICAT
Peking University Cancer Hospital & Institute
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer
Taichung Veterans General Hospital
Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels
Eastern Hepatobiliary Surgery Hospital